{'52WeekChange': -0.032558203,
 'SandP52WeekChange': 0.0644362,
 'address1': '951 Yamato Road',
 'address2': 'Suite 220',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 2.06,
 'askSize': 41800,
 'averageDailyVolume10Day': 7898400,
 'averageVolume': 6100466,
 'averageVolume10days': 7898400,
 'beta': 2.15014,
 'beta3Year': None,
 'bid': 2.04,
 'bidSize': 28000,
 'bookValue': -0.166,
 'category': None,
 'circulatingSupply': None,
 'city': 'Boca Raton',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 2.12,
 'dayLow': 1.78,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -4.013,
 'enterpriseToRevenue': 11.199,
 'enterpriseValue': 648967808,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 1.4657143,
 'fiftyTwoWeekHigh': 4.32,
 'fiftyTwoWeekLow': 0.85,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 244699684,
 'forwardEps': -0.3,
 'forwardPE': -6.933333,
 'fromCurrency': None,
 'fullTimeEmployees': 348,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.12668,
 'heldPercentInstitutions': 0.71239,
 'industry': 'Drug Manufacturers—Specialty & Generic',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': 1317600000,
 'lastSplitFactor': '1:100',
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/therapeuticsmd.com',
 'longBusinessSummary': "TherapeuticsMD, Inc. operates as a women's healthcare "
                        'company in the United States. The company offers '
                        'IMVEXXY for the treatment of moderate-to-severe '
                        'dyspareunia; BIJUVA, a bio-identical hormone therapy '
                        'combination of 17Ã\x9f-estradiol and progesterone for '
                        'the treatment of moderate-to-severe vasomotor '
                        'symptoms; and ANNOVERA, a ring-shaped contraceptive '
                        'vaginal system. Its preclinical projects include the '
                        'development of TX-005HR, a progesterone-alone '
                        'transdermal cream; TX-006HR, an estradiol and '
                        'progesterone transdermal cream; and TX-00THR and '
                        'TX-0008HR, which are transdermal patch product '
                        "candidates. The company's clinical development "
                        'product is TX-009HR, an oral progesterone and '
                        'estradiol formulation. It also manufactures and '
                        'distributes branded and generic prescription prenatal '
                        'vitamins under the vitaTrue, vitaPearl, vitaMedMD, '
                        'and BocaGreenMD Prena1 brands. The company sells its '
                        'prescription prenatal vitamin and hormone therapy '
                        'drug products to wholesale distributors and retail '
                        'pharmacy distributors. TherapeuticsMD, Inc. is '
                        'headquartered in Boca Raton, Florida.',
 'longName': 'TherapeuticsMD, Inc.',
 'market': 'us_market',
 'marketCap': 565100608,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_114205175',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -193487424,
 'nextFiscalYearEnd': 1640908800,
 'open': 1.92,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': -0.15,
 'phone': '561 961 1900',
 'previousClose': 1.98,
 'priceHint': 4,
 'priceToBook': None,
 'priceToSalesTrailing12Months': 9.751362,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 2.12,
 'regularMarketDayLow': 1.78,
 'regularMarketOpen': 1.92,
 'regularMarketPreviousClose': 1.98,
 'regularMarketPrice': 1.92,
 'regularMarketVolume': 6363456,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 271683008,
 'sharesPercentSharesOut': 0.305,
 'sharesShort': 82858273,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 82342141,
 'shortName': 'TherapeuticsMD, Inc.',
 'shortPercentOfFloat': 0.33830002,
 'shortRatio': 14.49,
 'startDate': None,
 'state': 'FL',
 'strikePrice': None,
 'symbol': 'TXMD',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -0.762,
 'twoHundredDayAverage': 1.566259,
 'volume': 6363456,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.therapeuticsmd.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '33431'}